On my spare time I enjoy cooking new recipes, going for a scenic run, hitting the weight room, or binge-watching many TV shows at once. I am a former personal trainer and still enjoy learning and ...

"Not everyone sees the desired weight loss on the currently marketed products. There have been side effects and numerous supply issues. There's uncertainty around how we're going to treat these ...

Whether you’re looking to liven up your lunchtime 5k, add heat to your home workouts or overcome a training plateau (or all of the above), strapping on a weighted vest is one of the easiest ways ...

Taking to Instagram Stories on Friday, the former ITV favourite shared a snap of himself lifting some weights in a pair of white shorts and a black T-shirt. "Leg day," Schofield captioned the snap.

Phillip Schofield has taken to social media to share a photo of himself working out in the gym to put back on the weight he lost while spending time on a remote island for his upcoming Channel 5 show.

Phillip is making his TV return at the end of September (Image: PA) Schofield, who during his break also severed ties with the Prince's Trust where he served as an ambassador, is poised to ...

Phillip Schofield has given fans a look at his weightlifting workout and "twiglet legs" as he prepares to make his return to TV screens after a year away from the spotlight.

Find anything you save across the site in your account Find anything you save across the site in your account All products are independently selected by our editors. If you buy something, we may ...

The IPO comes amid a surge of investor interest in a new class of weight loss medications known as GLP-1s. These drugs, which mimic a hormone that regulates appetite and blood sugar, have shown ...

(Reuters) - BioAge Labs has raised $198 million after pricing its upsized U.S. initial public offering at the midpoint of the range at $18 per share, the weight-loss drug developer said on Wednesday.

It is trading on the Nasdaq Global Select Market under the ticker symbol “BIOA.” The IPO comes amid a surge of investor interest in a new class of weight loss medications known as GLP-1s. These drugs, ...